Copyright
©The Author(s) 2016.
World J Respirol. Mar 28, 2016; 6(1): 42-48
Published online Mar 28, 2016. doi: 10.5320/wjr.v6.i1.42
Published online Mar 28, 2016. doi: 10.5320/wjr.v6.i1.42
Table 4 Cases of acute exacerbation of idiopathic pulmonary fibrosis
| Period (d) | ||
| From registry (last chemotherapy) to AE-IPF | From AE-IPF to death | |
| A group (n =1) | 136 | 66 |
| B group (n =16) | ||
| Case 1 CBDCA/PTX 2 cycles | 56 (27) | 20 |
| Case 2 CBDCA/PTX 2 cycles | 77 (47) | 16 |
| Case 3 CBDCA/PTX 3 cycles | 124 (101) | 6 |
| Case 4 CBDCA/PTX 3 cycles | 317 (249) | 24 |
| Case 5 CBDCA/PTX 3 cycles | ||
| → 2nd line PEM 1 cycle | 83 (12) | 18 |
| Case 6 CBDCA/PTX 3 cycles | ||
| → 2nd line PEM 4 cycles | 583 (14) | 8 |
- Citation: Ebi N, Tokunaga S, Itoh K, Okamoto I, Edakuni N, Fujii S, Watanabe K, Hayashi S, Maeyama T, Nakanishi Y. Multicenter cooperative observational study of idiopathic pulmonary fibrosis with non-small cell lung cancer. World J Respirol 2016; 6(1): 42-48
- URL: https://www.wjgnet.com/2218-6255/full/v6/i1/42.htm
- DOI: https://dx.doi.org/10.5320/wjr.v6.i1.42